The recall was initiated earlier this month on ... bottles of blood pressure-lowering drugs such as valsartan and losartan have been removed from the market since 2018 because they contained ...

This has led to recalls and increased scrutiny of manufacturing processes. More than 12 million bottles of blood pressure-lowering drugs such as valsartan and losartan have been removed from the ...

Losartan is an ARA that is licensed for treatment of hypertension and has a lower incidence of side effects than most ACE inhibitors. We recently treated a patient who developed reversible ...

Medscape Medical News, December 21, 2018 Torrent Pharma Recalls Two Lots of Tainted Losartan Tablets In the next chapter of the ongoing tainted-ARB saga, the recall covers certain lots of losartan ...